Home / Japan / Nxera Pharma Co.,Ltd.
Nxera Pharma Co.,Ltd.
Short position disclosed on August 3, 2026.
1.95% of the capital sold short
2 disclosing funds
2 disclosures on record
Open positions
| Fund | % of capital | Since |
|---|---|---|
| Citigroup Global Markets Limited | 1.00% | August 3, 2026 |
| Barclays Capital Securities Ltd | 0.95% | August 3, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 3, 2026 | Citigroup Global Markets Limited | 1.00% | still open |
| August 3, 2026 | Barclays Capital Securities Ltd | 0.95% | still open |
Other companies sold short in Japan
- eole Inc. 14.00% of the capital sold short
- KLab Inc. 12.65% of the capital sold short
- QD Laser,Inc. 10.98% of the capital sold short
- Unitika LTD. 10.64% of the capital sold short
- Jibannet Holdings Co.,Ltd. 10.53% of the capital sold short
- AKIBA Holdings Co.,Ltd. 8.65% of the capital sold short
- 3-D Matrix,Ltd. 8.53% of the capital sold short
- W-SCOPE Corporation 8.09% of the capital sold short
- Seven & i Holdings Co.,Ltd. 7.49% of the capital sold short
- Tri Chemical Laboratories Inc. 7.09% of the capital sold short
- Hokkaido Electric Power Company,Incorporated 6.72% of the capital sold short
- Nomura Micro Science Co.,Ltd. 6.71% of the capital sold short